Linical Co., Ltd. (2183.T) JPX
238.00
-2(-0.83%)
Currency In JPY
- General
- Statistics
- Historical Data
- Profile
- Financials
238.00
-2(-0.83%)
Currency In JPY
Address
Shin-Osaka Brick Building
Osaka, 532-0003
Japan
Phone
81 6 6150 2478
Website
Sector
Healthcare
Industry
Biotechnology
Employees
662
First IPO Date
October 27, 2008
| Name | Title | Pay | Year Born |
| Kazuhiro Hatano | President, Chief Executive Officer, Chief Strategy Officer, Chief Commercial Officer & Representative Director | 0 | 1965 |
| Keigo Tsujimoto | Executive Officer & Chief Project Officer | 0 | 1964 |
| Masaya Miyazaki | Executive Officer & Chief Asia Pacific Officer | 0 | 1971 |
| Clareece West | President & Chief Commercial Officer of Americas & Europe | 0 | N/A |
| Shiori Yamaguchi | Executive Officer & CCO | 0 | 1975 |
| Jun Kawai | Executive Officer & Chief Administrative Officer | 0 | 1968 |
| Satoru Toyota | Executive Officer & Head of Oncology Business Unit (HQ, Japan) | 0 | N/A |
| Tokuno Masayoshi | Executive Officer & Chief Information Officer | 0 | N/A |
| Toshiaki Nagafuji | Executive Officer, Chief Technology Officer & Head of Innovative Drug Development Business Unit (HQ, Japan) | 0 | N/A |
| Tracy Goeken | Chief Medical Officer | 0 | N/A |
Linical Co., Ltd. provides drug development services primarily in the areas of oncology and central nervous system to pharmaceutical companies worldwide. The company offers drug development consulting services, such as market analysis of products in development, regulatory affairs consultation support, and licensing support. It also provides clinical research and development, and contract medical affairs services, including front-end services comprising project management, monitoring, quality control, vendor management, auditing, and clinical research secretariat; and back-end services, which include data management, bio statistical analysis, medical writing, pharmacovigilance, and medical management. The company was incorporated in 2005 and is headquartered in Osaka, Japan.